Searchable abstracts of presentations at key conferences in endocrinology

ea0028p256 | Pituitary | SFEBES2012

Pituitary regrowth following growth hormone replacement therapy.

Evans Nicholas , Saada Janak , Swords Francesca , Temple Rosemary

Introduction: Growth hormone (GH)-deficiency in adults is associated with a range of adverse outcomes that improve with GH replacement. Pituitary adenomas and their treatment account for a large proportion of patients with adult GH-deficiency. However, safety fears have arisen due to the mitogenic effect of excess GH on pre-malignant colonic polyp formation in individuals with acromegaly. This, along with anecdotal suggestions of pituitary tumour recurrence, has prompted furth...

ea0059p024 | Adrenal and steroids | SFEBES2018

Current management of adrenal incidentalomas- a United Kingdom single centre experience

Allsop Daniel , Burgess Neil , Saada Janak , Ahluwalia Rupa , Chipchase Allison , Myint KhinSwe

Background: Adrenal incidentalomas (AI) are asymptomatic adrenal lesions found on imaging not primarily performed to detect adrenal disease. We conducted a retrospective audit of management of AI following European Society of Endocrinology recommendation (2016).Methods: This was a retrospective review of incidentaloma referrals over 9 months (June 2017–March 2018). Cases were identified using criterion search of the referral console. Additional data...

ea0059p029 | Adrenal and steroids | SFEBES2018

Management outcome of phaeochromocytoma over 10 years (2008–2018) in a Tertiary Centre, UK

Waife Eunice , Gaur Smriti , Burgess Neil , O'Hare Debbie , Saada Janak , Chipchase Allison , Swords Francesca , Myint KhinSwe

Introduction: Pheochromocytomas (adrenal and extra- adrenal/Paragangliomas) are rare catecholamine producing tumors and required complex dedicated MDTintervention. We preliminarily reported our service in a tertiary referral centre over 10 years (2008–2018).Method: A retrospectively review of confirmed phaeochromocytoma were carried out by reviewing clinical correspondences and ICE investigation-result system (laboratory, radiology and histology.)</...

ea0081ep34 | Adrenal and Cardiovascular Endocrinology | ECE2022

Single centre experience of assessment of adrenal incidentalomas – it’s time for a change

Naing Thin Kyi Phyu , Janebdar Husay , Jose Neetha , Saada Janak , Rochester Mark , Myint Khin Swe , Ahluwalia Rupa

Background: Adrenal incidentalomas (AIs) refer to adrenal masses discovered on imaging performed for conditions unrelated to suspected adrenal diseases. In an ageing population with improving radiological modalities, the detection of AIs has increased. While most are benign, non-functioning adenomas, some may represent functioning and/or malignant disease including adrenal carcinoma. Investigating AIs can be time-consuming and anxiety-inducing for patients, while under-investi...

ea0094p45 | Neuroendocrinology and Pituitary | SFEBES2023

Phaeochromocytoma/Paraganglioma – Call for Education and More Screening

Yung Zhuang Choo Alwyn , Ahluwalia Rupa , Joseph Neetha , Saada Janak , McArdle Nicholas , Chipchase Allison , Rochester Mark , Manson-Bahr David , Maxwell Melanie , Swe Myint Khin

Background: Phaeochromocytomas & paragangliomas (PPGL) are rare neuroendocrine tumours presenting with symptoms of sympathetic overactivity, hypertension, or as adrenal incidentalomas.Study and results: A 24-year retrospective review of a U.K. single-centre PPGL service (2009 -2023) identified 61 cases (53 phaeochromocytomas/8 paragangliomas). Among these, 35 (57%) were females. Mean age of diagnosis was 56.35&pm;16....